Therapeutic Apheresis and Long COVID
This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte stacking when extracorporeal apheresis is performed. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.
Make a Donation
FLCCC is dedicated to educating as many healthcare providers as possible across the globe and empowering patients with Long COVID or post vaccine injuries to take control of their own health. To help us continue this work, please consider donating to help us cover the costs of these conferences. For other donation options please visit our Donate page!
Share this Lesson
